Larson Financial Group’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$73.4K Sell
3,000
-234
-7% -$6.51K ﹤0.01% 1403
2026
Q2
$111K Buy
3,234
+1,009
+45% +$30.5K ﹤0.01% 1134
2026
Q1
$53K Sell
2,225
-12
-0.5% -$333 ﹤0.01% 1320
2025
Q4
$62K Buy
2,237
+270
+14% +$6.89K ﹤0.01% 1136
2025
Q3
$47.7K Buy
1,967
+1,923
+4,370% +$38.3K ﹤0.01% 1182
2025
Q2
$748 Buy
44
+14
+47% +$244 ﹤0.01% 2740
2025
Q1
$586 Hold
30
– – ﹤0.01% 2529
2024
Q4
$744 Sell
30
-43
-59% -$1.1K ﹤0.01% 2107
2024
Q3
$1.79K Buy
73
+43
+143% +$1.11K ﹤0.01% 1877
2024
Q2
$703 Hold
30
– – ﹤0.01% 1773
2024
Q1
$991 Buy
30
+20
+200% +$623 ﹤0.01% 1451
2023
Q4
$272 Hold
10
– – ﹤0.01% 1631
2023
Q3
$241 Hold
10
– – ﹤0.01% 1624
2023
Q2
$319 Hold
10
– – ﹤0.01% 1478
2023
Q1
$306 Hold
10
– – ﹤0.01% 1444
2022
Q4
$391 Hold
10
– – ﹤0.01% 1392
2022
Q3
$0 Hold
10
– – ﹤0.01% 1298
2022
Q2
$0 Hold
10
– – ﹤0.01% 1192
2022
Q1
$1K Hold
10
– – ﹤0.01% 953
2021
Q4
$1K Hold
10
– – ﹤0.01% 995
2021
Q3
$1K Hold
10
– – ﹤0.01% 811
2021
Q2
$1K Hold
10
– – ﹤0.01% 749
2021
Q1
$1K Buy
+10
New +$951 ﹤0.01% 745

Other funds holding BEAM

Larson Financial Group's BEAM Position: Q3 2026 in Review

Larson Financial Group reduced its Beam Therapeutics (BEAM) stake by 7.2% in Q3 2026, selling an estimated $6.51K and leaving 3,000 shares worth $73.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1403.

Larson Financial Group first reported a position in BEAM in Q1 2021 and has held it in 23 quarters since. The position peaked at $111K in Q2 2026. 264 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.

  • Larson Financial Group held 3,000 shares of Beam Therapeutics worth $73.4K as of Q3 2026.
  • Larson Financial Group sold 234 Beam Therapeutics shares in Q3 2026, an estimated $6.51K.
  • Beam Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #1403 holding.
  • Larson Financial Group first reported a position in Beam Therapeutics in Q1 2021 and has held it in 23 quarters since.
  • Larson Financial Group's Beam Therapeutics position peaked at $111K in Q2 2026.
  • 264 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.